Sign Up to like & get
recommendations!
1
Published in 2023 at "Journal of Medical Virology"
DOI: 10.1002/jmv.28756
Abstract: Chinese guidelines prioritize the use of Azvudine and nirmatrelvir–ritonavir in COVID‐19 patients. Nevertheless, the real‐world effectiveness of Azvudine versus nirmatrelvir–ritonavir is still lacking, despite clinical trials showing their effectiveness compared with matched controls. To compare…
read more here.
Keywords:
versus nirmatrelvir;
azvudine versus;
nirmatrelvir ritonavir;
ritonavir ... See more keywords